- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 99-113 of
249 results
1049 Exhibit: EX 1049
Document
IPR2020-01053, No. 1049-47 Exhibit - EX 1049 (P.T.A.B. Jun. 5, 2020)
|
|
Cite Document
1014 Exhibit: EX 1014
Document
IPR2020-01053, No. 1014-14 Exhibit - EX 1014 (P.T.A.B. Jun. 5, 2020)
|
|
Cite Document
1028 Exhibit: EX 1028, Horisawa, with translation from Japanese to English
Document
IPR2020-01053, No. 1028-28 Exhibit - EX 1028, Horisawa, with translation from Japanese to English (P.T.A.B. Jun. 5, 2020)
|
|
Cite Document
2096 Exhibit: Poyurovsky et al, Attentuation of Olanzapine Induced Weight Gainin ...
Document
IPR2020-01053, No. 2096-145 Exhibit - Poyurovsky et al, Attentuation of Olanzapine Induced Weight Gainin Patients with Schizophrenia (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2068 Exhibit: Samalin et al, Clinical potential of lurasidone in the management ofsc...
Document
IPR2020-01053, No. 2068-118 Exhibit - Samalin et al, Clinical potential of lurasidone in the management ofschizophrenia (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2137 Exhibit: Weiden, Partial Compliance and Risk of Rehospitalization AmongCalif...
Document
IPR2020-01053, No. 2137-155 Exhibit - Weiden, Partial Compliance and Risk of Rehospitalization AmongCalifornia Medicaid Patients with Schizophrenia, PsychiatricServices (P.T.A.B. Mar. 11, ...
|
|
Cite Document
2043 Exhibit: FDA Atypical Antipsychotic Drugs Information
Document
IPR2020-01053, No. 2043-92 Exhibit - FDA Atypical Antipsychotic Drugs Information (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2066 Exhibit: Reiffen et al, Generic Drug Industry Dynamics
Document
IPR2020-01053, No. 2066-116 Exhibit - Reiffen et al, Generic Drug Industry Dynamics (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2012 Exhibit: Sumitomo Dainippon Pharma Announces Resolution of Disputes Und...
Document
IPR2020-01053, No. 2012-60 Exhibit - Sumitomo Dainippon Pharma Announces Resolution of Disputes Under Consolidated Patent Infringement Lawsuit Regarding ANDAs for Latuda in the US (...
|
|
Cite Document
2041 Exhibit: Schizophrenia Symptoms, Patterns and Statistics and Patterns
Document
IPR2020-01053, No. 2041-90 Exhibit - Schizophrenia Symptoms, Patterns and Statistics and Patterns (P.T.A.B. Sep. 18, 2020)
|
|
Cite Document
2029 Exhibit: Weight Gain, Antipsychotic Drug Treatment and Pharmacogenomics
Document
IPR2020-01053, No. 2029-78 Exhibit - Weight Gain, Antipsychotic Drug Treatment and Pharmacogenomics (P.T.A.B. Sep. 18, 2020)
|
|
Cite Document
2013 Exhibit: Treatment of Schizophrenia and Spectrum Disorders
Document
IPR2020-01053, No. 2013-61 Exhibit - Treatment of Schizophrenia and Spectrum Disorders (P.T.A.B. Sep. 18, 2020)
|
|
Cite Document
2014 Exhibit: Novel antipsychotics
Document
IPR2020-01053, No. 2014-62 Exhibit - Novel antipsychotics (P.T.A.B. Sep. 18, 2020)
|
|
Cite Document
2038 Exhibit: Ziprasidone 80 mgday and 160 mgday in the Acute Exacerbation of S...
Document
IPR2020-01053, No. 2038-87 Exhibit - Ziprasidone 80 mgday and 160 mgday in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder (P.T.A.B. Sep. 18, 2020)
|
|
Cite Document
2017 Exhibit: A Short History of Bipolar Disorder
Document
IPR2020-01053, No. 2017-66 Exhibit - A Short History of Bipolar Disorder (P.T.A.B. Sep. 18, 2020)
|
|
Cite Document
